Yoon Soo-Jee, Choi So-Rae, Kim Dol-Mi, Kim Jun-Uh, Kim Kyung-Wook, Ahn Chul-Woo, Cha Bong-Soo, Lim Sung-Kil, Kim Kyung-Rae, Lee Hyun-Chul, Huh Kap-Bum
Department of Internal Medicine, Yongdong Severance Hospital, Yonsei University College of Medicine, 146-92 Dogok-dong, Kangnam-gu, Seoul 135-720, Korea.
Yonsei Med J. 2003 Apr 30;44(2):227-35. doi: 10.3349/ymj.2003.44.2.227.
Lifelong thyroid hormone replacement is indicated in patients with hypothyroidism as a result of Hashimoto's thyroiditis. However, previous reports have shown that excess iodine induces hypothyroidism in Hashimoto's thyroiditis. This study investigated the effects of iodine restriction on the thyroid function and the predictable factors for recovery in patients with hypothyroidism due to Hashimoto's thyroiditis. The subject group consisted of 45 patients who had initially been diagnosed with hypothyroidism due to Hashimoto's thyroiditis. The subjects were divided randomly into two groups. One group was an iodine intake restriction group (group 1) (iodine intake: less than 100 micro g/day) and the other group was an iodine intake non-restriction group (group 2). The thyroid-related hormones and the urinary excretion of iodine were measured at the baseline state and after 3 months. After 3 months, a recovery to the euthyroid state was found in 78.3 % of group 1 (18 out of 23 patients), which is higher than the 45.5% from group 2 (10 out of 22 patients). In group 1, mean serum fT4 level (0.80 +/- 0.27 ng/dL at the baseline, 0.98 +/- 0.21 ng/dL after 3 months) and the TSH level (37.95 +/- 81.76 micro IU/mL at the baseline, 25.66 +/- 70.79 micro IU/mL after 3 months) changed significantly during this period (p < 0.05). In group 2, the mean serum fT4 level decreased (0.98 +/- 0.17 ng/dL at baseline, 0.92 +/- 0.28 ng/dL after 3 months, p < 0.05). In the iodine restriction group, the urinary iodine excretion values were higher in the recovered patients than in non-recovered patients (3.51 +/- 1.62 mg/L vs. 1.21 +/- 0.39 mg/ L, p=0.006) and the initial serum TSH values were lower in the recovered patients than in the non-recovered patients (14.28 +/- 12.63 micro IU/mL vs. 123.14 +/- 156.51 micro IU/mL, p=0.005). In conclusion, 78.3% of patients with hypothyroidism due to Hashimoto's thyroiditis regained an euthyroid state iodine restriction alone. Both a low initial serum TSH and a high initial urinary iodine concentration can be predictable factors for a recovery from hypothyroidism due to Hashimoto's thyroiditis after restricting their iodine intake.
对于因桥本甲状腺炎导致甲状腺功能减退的患者,需终身进行甲状腺激素替代治疗。然而,既往报道显示,碘过量可诱发桥本甲状腺炎患者发生甲状腺功能减退。本研究探讨了碘限制对桥本甲状腺炎所致甲状腺功能减退患者甲状腺功能的影响以及恢复的可预测因素。研究对象为45例最初被诊断为桥本甲状腺炎所致甲状腺功能减退的患者。将受试者随机分为两组。一组为碘摄入限制组(第1组)(碘摄入量:每日少于100微克),另一组为碘摄入非限制组(第2组)。在基线状态和3个月后测量甲状腺相关激素及尿碘排泄量。3个月后,第1组78.3%(23例患者中的18例)恢复到甲状腺功能正常状态,高于第2组的45.5%(22例患者中的10例)。在第1组中,此期间平均血清游离甲状腺素(fT4)水平(基线时为0.80±0.27纳克/分升,3个月后为0.98±0.21纳克/分升)和促甲状腺激素(TSH)水平(基线时为37.95±81.76微国际单位/毫升,3个月后为25.66±70.79微国际单位/毫升)有显著变化(p<0.05)。在第2组中,平均血清fT4水平下降(基线时为0.98±0.17纳克/分升,3个月后为0.92±0.28纳克/分升,p<0.05)。在碘限制组中,恢复患者的尿碘排泄值高于未恢复患者(3.51±1.62毫克/升对1.21±0.39毫克/升,p = 0.006),且恢复患者的初始血清TSH值低于未恢复患者(14.28±12.63微国际单位/毫升对123.14±156.51微国际单位/毫升,p = 0.005)。总之,78.3%的桥本甲状腺炎所致甲状腺功能减退患者仅通过碘限制即可恢复到甲状腺功能正常状态。初始血清TSH水平低和初始尿碘浓度高均可能是桥本甲状腺炎所致甲状腺功能减退患者在限制碘摄入后恢复的可预测因素。